Health Canada’s COVID-19 Interim Guidance on Hand Sanitizers

by Nikita Angane | Aug 19, 2020 | Coronavirus, COVID-19, FDA, Medical Devices, Quality, Regulatory

Health canada's COVID-19 hand sanitizers

Hand sanitizers in Canada are regulated by the Natural and Non-Prescription Health Products Directorate (NNHPD). When the pandemic was at its peak, NNHPD released an interim guidance for expedited approval of hand sanitizers to help mitigate supply shortages. The expedited process allowed for manufacturers to obtain a site license and a product license by implementing any of the following GMPs:¹

Part 3 of the NHPR
Division 2 of the Food and Drug Regulations
Guide to Food Safety, or
Good Manufacturing Practices for Cosmetic Products

Companies obtaining a site license were also exempted from providing a Quality assurance report or evidence of GMP implementation.

On July 13, 2020, Health Canada rescinded its interim guidance for expedited approval of hand sanitizers and is now processing site license and product license application as per its regular service standards. This means that hand sanitizers must be manufactured, distributed, imported, labeled, and packaged in accordance with Part 3 of the Natural Health Products Regulations (SOR/2003-196).²

Companies obtaining site licenses will have to provide evidence of GMP compliance by either submitting a product report or by submitting certificates of compliance to the other internationally recognized standards. According to Health Canada, product licenses issued under the previous expedited licensing approach were not temporary and remain valid. However, manufacturers, packagers, labelers, and importers will require a valid site license once the regular supply of hand sanitizers stabilizes.²

Companies that received an interim site license under the previous expedited attestation process will be notified when the interim period ends (when the demand for alcohol-based hand sanitizers stabilizes). When notified, companies will have 60 days to stop manufacturing, importing, packaging, labeling or distributing alcohol-based hand sanitizers and apply for a valid site license to continue producing hand sanitizers until they receive a decision on their application.²

Are you planning to sell your hand sanitizer in Canada? Call us today at 248-987-4497 or email us at info@emmainternational.com for more information.

¹Health Canada- ARCHIVED: Guide on Health Canada’s interim expedited licensing approach for the production and distribution of alcohol-based hand sanitizers retrieved on 08/12/2020 from https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/covid-19-expediated-licensing-alcohol-hand-sanitizer/archive-01.html

²Health Canada (July 2020) Licensing approach to produce and distribute alcohol-based hand sanitizers: guidance document retrieved on 08/12/2020 from https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/covid-19-expediated-licensing-alcohol-hand-sanitizer.html

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

See All Resources

Health Canada’s COVID-19 Interim Guidance on Hand Sanitizers

Nikita Angane

More Resources

Change Management And Control

Aseptic Technique and Gowning

Importance of Pharmaceutical GMP

Ready to learn more about working with us?

Thank you for subscribing!

Pin It on Pinterest